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The introduction  of defned haptenic determinants  into immunogenic carriers by 
Landsteiner  (1) has provided a poweriul tool for the analysis of specific interactions 
between antigens and specific ceils in the immune response. Considerable evidence has 
been obtained demonstrating that cellular immune reactions to hapten-protein conju- 
gates (delayed sensitivity [2-@ stimulation of DNA synthesis by antigen [7, 8], and 
hapten-specific  secondary responses  [9-111) display  a  significant  although  variable 
degree of carrier specificity.  Such carrier specificity of hapten-specific cellular reactions 
was initially interpreted to reflect the partial specificity of the antigen-binding recep- 
tors  of specific  cells  for the  carrier  molecule  (12-16),  paralleling  the  demonstrated 
carrier specificity  of anfi-hapten humoral antibodies (16-18). 
This interpretation  of carrier function, however, is not able to explain several es- 
sential characteristics of hapten-specific immune responses: 
(a) The magnitude of the carrier specificity of cellular immune reactions cannot be 
easily explained by the relatively modest contribution, in energetic terms, of the car- 
rier molecule to the specificity  of most anti-hapten humoral antibodies (16-18): 
(b) Hapten conjugates of immunogenic molecules are required to elicit strong anti- 
hapten antibody responses; nonimmunogenic substances serve only poorly, or not at 
all,  as carriers for haptens  (19-21). 
(e) The induction of immunological unresponsiveness to the carrier molecule results 
in the partial or total suppression of the responses to haptens on the tolerated proteins 
(22-27). 
If the specificity of serum antibody accurately expresses  the specificity of the antigen- 
binding receptors present on the precursors of antibody forming cells, then these find- 
ings suggest the operation o[ an additional recognition mechanism for the carrier mole- 
cule. This interpretation would be strengthened if cooperation between carrier-specific 
and hapten-specific cells were found to be essential for the development of anti-hapten 
immune responses. According to this view, cells capable o[ reacting with carrier mole- 
cules should interact with  the  antigen be[ore anti-hapten  antibody producing cells 
could be stimulated by hapten-protein conjugates. 
Mitchison (28) and Rajewsky et al.  (29), have recently demonstrated such coopera- 
tion between carrier-specific cells  and hapten-specific cells  in anti-hapten  secondary 
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responses. Making use of the observation of Ovary and Benacerraf (9)  that hapten- 
specific anamnestic responses display marked carrier specificity, Mitchison (28) showed 
that the injection of spleen cells obtained from mice immunized to bovine serum albu- 
min (BSA) together with spleen cells from mice immunized with 4-hydroxy-3-iodo-5- 
nitrophenyl-ovalbumin (NIP-OVA) into irradiated syngeneic recipient mice enabled 
NIP-BSA to elicit strong anti-hapten secondary responses and to bypass the carrier 
specificity of the primary NIP-OVA immunization. Similarly Rajewsky et al.  (29) re- 
ported that supplemental immunization with human gamma globulin (HGG)  enabled 
rabbits primed with a p-azophenylsulfonic acid conjugate of BSA (Sulf-BSA) to form 
an anti-hapten secondary response to Sulf-HGG. 
The  present  studies  confirm  and  extend  the  earlier  observations  of  cell 
cooperation  between  carrier-specific and  hapten-specific cells in  anti-hapten 
antibody  synthesis.  The  current  paper  demonstrates  that  2,4-dinitrophenyl 
(DNP)  bovine  gamma  globulin  (BGG)  elicits  hapten-specific  secondary  re- 
sponses  in  rabbits  or  guinea  pigs  given  primary  immunization  with  DNP- 
ovalbumin  (OVA)  if  those  animals have  also been  immunized,  in  an  appro- 
priate way, with an optimal dose of unconjugated BGG. In addition, we show 
that:  (a)  Preimmunization  with BGG markedly augments  the primary anti- 
hapten  antibody response to DNP-BGG  in both  rabbits and guinea pigs.  (b) 
Transfer of anti-B GG sera into DNP-OVA immunized animals does not prepare 
them for an  anti-DNP  response to DNP-BGG.  (c)  The immunoglobulin class 
and the affinity of the anti-hapten antibody is characteristic of the mode and 
time of immunization with the hapten-carrier complex and not with that of the 
supplemental carrier. 
Materials and Methods 
Proteins and Chemical Reagents.--Hen  ovalbumin  (OVA), 5 X  recrystallized  and bovine 
gamma globulin  (BGG)  were  obtained from  Pentex  Biochemicals,  Kankakee,  Ill. Bovine 
fibrinogen  (BF)  was  obtained from  Armour Pharmaceutical Co., Kankakee, Ill. 
1-fluoro-2,4-dinitrobenzene  (DNFB), p-dioxane,  and chloramine-T  were purchased from 
Eastman  Organic  Chemicals,  Rochester,  N.Y.  2,4-dinitrophenol (DNP-OH)  was  obtained 
from Fisher Scientific Company,  Springfield, N.J. and was recrystallized from water before 
use.  Epsilon-amino-N-caproic  acid (EACA)  and streptomycin sulfate were purchased from 
Mann  Research Labs,  Inc.,  N.Y.,  and  disodium  ethylenedinitrilo tetra-acetate  (EDTA) 
from  Matheson Scientific, Inc., Cincinnati, Ohio. a-tertiary-butyloxycarbonyl-L-lysine  ace- 
tate (a-t-boc-lysine)  was obtained from Cyelo Chemical  Corp., Los Angeles, Calif. Sodium 
lauryl sulfate was recrystallized  from 95% ethanol before use. 
Preparation of Dinitrophenylated (DNP) Proteins---2,4-dinitrophenylated  (DNP) proteins 
were prepared by the reaction, at alkaline pH, of DNFB with proteins as previously described 
(5). DNP-conjugated proteins were extensively dialyzed in the cold; their nitrogen content 
was determined by micro-Kjeldahl  analysis, and their DNP content was calculated from their 
absorbancy at 360 m# (e at 360 m# for ~-DNP-L-lysine =  17,400 (30). The following DNP- 
proteins were prepared: DNPT-OVA, DNP28-BGG  and  DNP109-BF. Subscripts refer to the 
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Preparation of Radioactive Compounds.-- 
Tritiated DNP-EA CA :  1-fluoro-2,4-dinitrobenzene-3H  (3H-DNFB)  was  obtained  from 
Amersham/Searle, Chicago, Ill.  (specific activity  =  10  c/mM).  ~H-DNFB was reacted with 
a  100-fold molar excess of EACA dissolved in 0.1  ml of 5% Na2CO3.  Mter being stirred at 
ambient  temperature for 2  hr,  the  reaction mixture was applied  to  analytical  thin layer 
chromatographic plates  composed of  silica  gel. The  chromatograms were  developed with 
n-butanol and the portion of silica containing 3H-DNP-EACA, as determined from the migra- 
tion of nonradioactive DNP-EACA, was scraped from the plates. The product was eluted 
from the silica gel with phosphate buffered saline (PBS; 0.01  ~  potassium phosphate, 0.15 
NaC1, pH 7.6). 
Tritlated  ~-DNP-L4ysine:  3H-DNFB  was  reacted  with  a-t-boc-lysine under  the  same 
conditions as described above for EACA. After being stirred for several hours at ambient tem- 
perature, 0.1  ml of 12  N HC1 was added to remove the t-boc group. 1 hr later, the mixture 
was chromatographed on silica gel using n-butanol:acetic acid:water (4:1:1)  as the develop- 
ing solvent. The final  steps in isolating the ~H-E-DNP-L-lysine  were identical to those de- 
scribed for 3H-e-DNP-EACA. 
Radioiodinated proteins: Proteins were iodinated in the cold by the chloramine-T method 
(31, 32) using carrier-free 125NaI (New England Nuclear Corp., Boston, Mass.). 
Immunizations.--Adult,  inbred strain 2 guinea pigs weighing 250-400  g  and adult  New 
Zealand white rabbits weighing 2.54.0 kg were obtained from the Animal Production Section, 
National Institutes of Health, Bethesda, Md.  Guinea pigs received primary  immunization 
with 1.0 mg DNPwOVA, in PBS, intraperitoneally on 3 successive days. 1 wk later, they re- 
ceived a supplemental immunization in the footpads, with either 1 or 50 #g of BGG emulsified 
in  complete Freund's adjuvant  (CFA,  Difco Laboratories, Detroit,  Mich.)  or with saline 
emulsified in CFA. 4 wk after initial immunization, the guinea pigs received a secondary im- 
munization with 1.0 mg of DNPwOVA or DNP28-BGG in PBS. This was administered as a 
200 #g intradermal dose followed 4 hr later by an 800/zg intraperitoneal dose. Animals were 
bled just prior to the boost (day 0)  and 4  (day 4)  and 7  (day 7)  days later, and antibody 
determinations were performed as described below. 
The basic protocol for rabbit immunization was similar. Rabbits received a primary im- 
munization consisting of 3 mg of DNPwOVA injected intravenously daily for 3 days. 1 wk 
later, a supplemental immunization with either 1 or 50 #g of BGG, as CFA emulsion, was ad- 
ministered subcutaneously. 5 wk after the primary immunization, 5 mg of DNPT-OVA  or of 
DNP28-BGG in PBS was injected intraperitoneally as a  secondary immunization. Animals 
were bled just prior to the booster injection and 4 and 7 days later. 
Several modifications of this general protocol were employed; these are described in the 
Results section of the paper. 
Preparation of Anti-BGG Antisera.--Rabbit and guinea pig anti-BGG antisera were pre- 
pared in the following  manner: Rabbits were immunized with 500 #g of BGG emulsified  in 
CFA and bled 2 wk later. The antiserum obtained from this first bleeding will hereafter be 
referred to as "early" anti-BGG antiserum. 7 wk after the primary immunization, all rabbits 
were boosted intraperitoneally with 5.0 mg of B GG in saline and were bled 1 1/2 and 3 wk after 
this secondary immunization. Sera from these last two bleedings were pooled and are hereafter 
referred to as "late" anti-BGG antisera. Guinea pigs were bled 3 wk after a single immuniza- 
tion with 50 #g of BGG in CFA. Sera from 17 guinea pigs were pooled and the anti-BGG 
antibody content determined by quantitative precipitin analysis. The  anti-BGG antibody 
content of early and late antisera from individual rabbits was similarly determined. 
Antibody Measurements.-- 
Quantitative precipitln analyses: Precipitin analyses were carried out as described by Eisen 
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1 hr, the reaction mixtures were held at 4°C for 48 hr before analysis. Washed specific precipi- 
tates were dissolved in 0.02 M sodium lauryl sulfate and absorbancies at 278 and 360 m# were 
determined. After correcting for the antigen present as indicated by the 360 m# absorbancy, 
the amount of anti-DNP antibody precipitated was calculated from the 278 m# absorbancy 
taking the extinction coefficients  (El~m) for rabbit and guinea pig anti-DNP antibodies at 
278 m# as 13.5 and 13.2, respectively (33, 34). 
Measurement  of anti-DNP  antibodies:  Although high levels of anti-DNP  antibody are 
satisfactorily determined by quantitative precipitin analyses, this technique is not suitable 
for measuring low levels of anti-DNP antibody because of the significant degree of nonspecific 
precipitation observed with highly conjugated DNP-proteins and normal sera (35). A recently 
described (35) modification of the Farr technique (36) was used to determine anti-DNP anti- 
body levels. To 0.1 rnl of antiserum (undiluted and serially  diluted 10-fold to 1:1000  in 20% 
normal homologous  serum) was added 0.1 ml of 1 X  10  -8 M  3H-DNP-EACA. After 1 hr at 
4°C, two volumes of 75% saturated ammonium sulfate (SAS) was added. (66% SAS was used 
for undiluted guinea pig antiserum.) The samples were mixed and held at 4°C for 30 min and 
then centrifuged at 2500 rpm for 30 min. A 0.2 ml aliquot of each superuatant was added to 
10 ml of a  scintillation solvent consisting of 25 parts toluene, 5 parts Bio-Solv-3  (Beckman 
Instruments,  Inc., Fullerton,  Calif.)  and  1 part  Liquifluor (New  England Nuclear  Corp., 
Boston, Mass.); radioactivity was measured in  a  liquid  scintillation spectrometer. Control 
samples contained PBS rather than antiserum. The percentage of binding of the ligand by 
each antiserum and its dilutions was calculated. Nonspecific binding of the ligand by normal 
nonimmune rabbit  and  guinea pig sera was usually  less  than  10%.  For each experiment, 
binding curves were constructed with  selected rabbit  and  guinea pig anti-DNP antisera, 
which had been analyzed by the quantitative precipitin technique. Using these curves, the 
percentage of binding of all  other antisera in each experiment were converted into amounts 
of anti-DNP antibody in micrograms per milliliter.  This conversion is valid if the unknown 
and standard antibodies have similar affinities. In each case, the standard antisera were chosen 
with the expectation that their affinity would be similar to that of the antisera being analyzed. 
The geometric means and  standard errors of anti-DNP antibody concentrations were cal- 
culated. 
Measurement ofanti-BGG antibodies:  Passive hemagglutination with BGG adsorbed tanned 
sheep erythrocytes was carried out as described by Boyden (37) and Stavitsky (38). Antisera 
to be tested and normal sara used for diluents were decomplemented at 56°C for 1 hr and ab- 
sorbed with washed sheep erythrocytes. The specificity of the reactions was verified  by ap- 
propriate controls and by specific inhibition of hemagglutination by BGG. All tests were per- 
formed with microtiter equipment (Cooke Engineering Co., Alexandria, Va.). The geometric 
mean of the reciprocal of the titers is presented. 
Quantitative  determination  of  precipitating  anti-BGG  antibody  was  performed  with 
125I-BGG as follows:  0.2  ml of antiserum was reacted with 0.1  ml  of  I25I-BGG  in varying 
concentrations ranging from 10 to 3200 #g/ml. The mixtures were kept at 37°C for 1 hr and 
then at 4°C for 24 hr. The samples were centrifuged at 2500 rpm for 30 min in the cold, and 
the radioactivity of an aliquot of each supernatant was measured in a NaI crystal scintillation 
counter. Controls consisted of normal homologous serum mixed with each of the I~SI-BGG 
concentrations used. The per cent and amount of antigen precipitated at each antigen con- 
centration by 0.2  ml of antiserum were calculated. Curves were constructed by plotting per 
cent antigen precipitated against antigen concentration. From these curves, the antigen con- 
centration at which 50% of added antigen was precipitated was determined (P~0). 
Ps0 is  expressed as micrograms of BGG added per milliliter of antiserum. 
Purification of AntI-DNP Antibodles.--Antibodies specific for the DNP-determinant were 
prepared by the method of Farah et al. (39). Specific precipitates were formed by the reaction 
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bodies were eluted with 0.1 M  DNP-OH. DNP-BF was precipitated with streptomycin sulfate 
(35 mg/ml) and DNP-OH was removed by extensive dialysis. 
Preparation of Guinea Pig "h-Globulin and Anti-Guinea Pig Globulin Antisera.--Guinea 
pig "F2-globulin  was separated from the globulin fraction of pooled normal guinea pig serum 
by ion-exchange chromatography using DEAE-cellulose equilibrated with 0.01 ~ phosphate 
buffer, pH 8.0 (40). Purity of the "y~-fraction  was confirmed by immunoelectrophoresis (41). 
Rabbit antisera specifically directed against guinea pig "rl-globulin and pepsin-digested frag- 
ments of guinea pig "y2-globulin,  F(ab)2 t, were obtained as previously described (42). Anti-')', 
antiserum was repeatedly absorbed with purified ~'2-globulin  until no further precipitation 
could be observed. After absorption with "y2-globulin,  the anti-'y, antiserum precipitated less 
than 2%  of  125I-labeled "y2-globulin  in contrast  to unabsorbed  anti-'),, which precipitated 
27-30%. Anti-3~ antiserum absorbed with F(ab)2 ~  was the gift of Dr. Victor Nussenzweig  and 
precipitated 96% of purified 1%I-'r~-globulin. 
Measurements of Antibody-Bindlng A~nities.--Average  association constants were calcu- 
lated for the binding of anti-DNP antibodies to 8H-DNP-L-lysine  from data obtained by an 
ammonium sulfate precipitation technique (43) and were termed K~. In order to determine 
the total concentration of antigen-binding sites present, 20 #l of undiluted serum were mixed 
with 10 #l of 3H-e-DNP-L-lysine.  The final concentration of the latter ranged from 0.167 X 
10  -5 M to 5.337 )< 10  -5 M. The total site concentration was determined from a plot of bound 
hapten versus free hapten,  after  correction for nonspecific precipitation.  KF'S for primary 
response anti-DNP antibodies were also calculated from  this  data.  To  determine KF for 
secondary response anti-DNP antibodies, an antibody concentration  of  1 >(  10  -7 M and 
8FI-e-DNP-L-lysine  concentrations ranging from 0.5 to 8 X  10  -s ~t were used in the binding 
assay. Utilizing the expression: 
B/F =  KF(Abo -- B) 
where B is concentration of bound hapten, F is concentration of free hapten, and Abo is the 
total antibody site concentration, KF was calculated from plots of B/F versus B. 
RESULTS 
Enhancement of Hapten-Specific Anamnestic Responses by Carrier Preimmuni- 
zation.--Guinea  pigs  and  rabbits  were  immunized according  to  the  general 
protocols described in the  methods section and outlined in Tables I  and II. 
Table I  and Fig. 1 present the results obtained in strain 2 guinea pigs; Table 
II and Fig. 2 present similar data for rabbits. 
When DNP is presented on the same carrier molecule (OVA) for both pri- 
mary and secondary immunizations, a  clear secondary response is obtained in 
guinea pigs and rabbits (Tables I  and II, Group A). On the  other  hand,  sec- 
ondary immunization with DNP  on a  different carrier (BGG) does not elicit 
an  anti-DNP response  in  guinea pigs,  and  evokes  a  small,  but  significant, 
increase in anti-DNP antibodies in rabbits (Tables I  and II, Group B). (Similar 
observations of  secondary anti-hapten responses in rabbits immunized with 
heterologous carrier conjugates have been reported previously [10, 44, 45]). 
However,  when  a  supplemental immunization with unconjugated BGG in 
CFA is given prior to secondary immunization with DNP2s-BGG, a  markedly 
enhanced secondary anti-DNP response is obtained in both species (Tables I 266  CARRIER  FUNCTION  IN  ANTI-HAPTEN  RESPONSES 
and II,  Groups C  and D).  The magnitude  of the response is  determined by 
the amount of BGG used for supplemental immunization. Thus, in guinea pigs 
a dose of 50 #g is significantly more effective than is 1 #g, whereas in rabbits 
TABLE I 
Enhancement  of Hapten-Specific  Secondary  Responses  in  Guinea  Pigs by  Preimmunization  "with the 
Carrier Molecule 
Group 
Anti-BGG antibody 
Immunization protocol  Num-  Anti-DNP antibody (/*g/m/)*  titer* 
bet of 
Primary  Supplement  Secondary  animals  Day  Day  Day  Boost,  ¢  Day  Day  Boost:~ 
0  4  7  0  7 
A  DNP7-OVA  CFA  DNPT-OVA  10  3.2  9.0  73.4  70.2  0  0  0 
B  DNP7-OVA  CFA  DNP2s-BGG  7  14.7  6.2  14.1  --0, 6  0  0  0 
C  DNPT-OVA  BGG-CFA  DNP28-BGG  4  3.9  3,9  143.0  139.1  91  609  518 
(1/*g) 
D  DNP7-OVA  BGG-CFA  DNP2s-BGG  9  4.2  26.7  626.0  621.8  4798  20.838  16,040 
(50 pg) 
E  DNP7-OVA  OVA-CFA  DNP7 OVA  5  0.82  31,2  603.4  602.6  N.D.§  N.D. 
(50/*g) 
* The data are expressed as geometric means. 
:~ Represents the increase in mean antibody levels or titers from day 0 to day 7, 
§ N.D.,  not determined. 
TABLE II 
Enhancement  of Hapten-Specific  Secondary  Responses  in Rabbits by Preimmunization with the Carrier 
Molecule 
Anti-DNP antibody  Anti-BGG antibody 
Immunization protocol  Num-  (/*g/ml)*  titer* 
Group  ber of 
Primary  Supplement  Secondary  animals Day  Day  Day  Boosts  Day  Day  Boost:~ 
0  4  7  0  7 
A  DNPT-OVA  BGG-CFA  DNP7-OVA  15  1.9  43,6  108.5  106.6  979  2842 
(so/*g) 
B  DNPT-OVA  CFA  DNP28-BGG  15  3.2  4.5  12,1  8.9  0  48 
C  DNPT-OVA  BGG-CFA  DNP28-BGG  8  3.4  40.9  276.9  273.5  76  1884 
(1/*g) 
D  DNPT-OVA  BGG-CFA  DNP28-BGG  8  4.1  25.8  69.7  65.6  1878  13,883 
(50/*g) 
E  DNP7-OVA  BGG-AIum  DNP28-BGG  4  1.1  6.1  9.3  8.2  64  861 
(9 rag) 
F  DNP7-OVA  BGG Saline  DNP~s-BGG  4  1.2  20.6  43,3  42.1  N.D,§  N.D. 
(15 rag) 
G  DNPT-OVA  Saline  DNP28-BGG  5  2.4  2.1  14.8  12.4  N.D.  N.D. 
1863 
48 
1808 
12,008 
797 
* The data are expressed as geometric means. 
:~ Represents the increase in mean antibody levels or titers from day 0 to day 7. 
§ N.D.,  not determined. 
1 #g appears to be the optimal dose. Moreover, supplemental immunization is 
most effective when BGG is injected in CFA; alum-precipitated BGG admin- 
istered intravenously (3.0 nag for 3 successive days) did not significantly affect 
the secondary anti-DNP response of rabbits to DNP28-BGG (Table lI, Group D.  It.  KATZ~  W,  E.  I~AUL~ E.  A.  GOIDL~  ]3.  BENACERRAF  267 
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E).  Nevertheless,  rabbits  which  received  soluble  BGG  intraperitoneally  (5.0 
mg on 3  successive  days)  for supplemental  immunization  manifested  an  en- 
hanced  anti-DNP  response  (Table II, Group F)  comparable in magnitude  to 
that of rabbits  given 50/zg of BGG in CFA (Table II, Group D)  and signifi- 
cantly greater  than  the  controls  (Table  II,  Group  G).  Some  correlation  was 
noted between the anti-hapten and anti-carrier secondary responses to DNP28- 
BGG in both species. 
The data presented demonstrate clearly that anti-hapten secondary responses 
to a  hapten conjugate of a  heterologous carrier  can be considerably enhanced 
by  supplemental  preimmunization  with  such  a  carrier  molecule.  This  phe- 
nomenon is best seen when the serum anti-hapten  antibody concentration of 
the  primed animals is low at the time  of secondary challenge,  as occurs with 
primary immunization  without  adjuvants,  and  when  the  supplemental  pre- 
immunization of the second carrier is administered with adjuvant.  Under  these 
circumstances  the  anti-DNP  response  of DNPT-OVA primed animals  supple- 
mentally immunized with BGG in CFA is consideraby greater to DNP2s-BGG 
than is the normal secondary to DNPwOVA (Tables I  and II). 
However, using the  same type of experimental  protocol  cooperative effects 
between  carrier  and  hapten  immunizations  can  be  demonstrated  without 
resorting  to  the  use  of different  carrier  proteins  for  primary  and  secondary 
challenge.  Thus,  as  shown  in Table  I  (Group  E)  the  anti-DNP  response  to 
DNPT-OVA of guinea pigs  primed  with  DNPT-OVA in  saline  was  markedly 
enhanced  by  supplemental  preimmunization  with  50  /zg  of  OVA  in  CFA, 
administered  1 wk after primary immunization.  This response was essentially 
equivalent  to  that  of  animals  immunized  with  DNPT-OVA,  supplementally 
immunized with 50/zg of BGG in CFA and boosted with DNP2s-BGG (Table 
I, Group D). 
Enhancement of ttapten-Specific Primary Responses by Carrier Preimmuniza- 
tion.--Guinea pigs and rabbits  were preimmunized with BGG or OVA either 
FIG. 2. Enhancement  of hapten-specific anamnestic responses by carrier preimmunization 
in rabbits. 
Primary immunization with 9.0 mg of DNPwOVA, administered intravenously  in saline, 
was performed at week 0. 1 wk later  supplemental immunization with either  1 #g of BGG 
emulsified in CFA or with a saline-CFA emulsion was carried out. 5 wk after primary immuni- 
zation  the animals were challenged with  5.0 mg of either  DNP2s-BGG  or DNPT-OVA in 
saline. Serum anti-DNP antibody concentrations just prior to challenge and on days 4 and 7 
are illustrated. The numbers in parentheses refer to the numbers of animals in the given groups. 
The lowermost panel illustrates the normal secondary response of DNP-OVA-primed animals 
to DNP-OVA challenge; the middle panel  shows the meager secondary response to DNP- 
BGG in DNP-OVA-primed animals, and furthermore demonstrates  the failure of transfused 
anti-BGG  serum to augment this response. The uppermost panel presents the enhancement 
of the secondary response to DNP-BGG in DNP-OVA-primed rabbits which have been sup- 
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in  saline  or  emulsified in  CFA.  Guinea  pigs received primary  immunization 
with 1.0 mg of DNP28-BGG or DNPT-OVA in saline 3 wk later. Rabbits received 
primary immunization with an intraperitoneal dose of 5.0 mg of DNP~8-BGG 
in saline 4  wk later. Control animals were preimmunized with saline emulsified 
in CFA. The protocols are outlined in Tables III and IV. 
The  guinea  pig  experiments  are  summarized  in  Table  III  and  presented 
graphically in Fig. 3. The normal primary anti-DNP response to a single dose 
of antigen in saline intraperitoneally is very meager in guinea pigs (Groups A 
TABLE III 
Enhancement  ~1" Hapten-Specific  Primary Responses  in Guinea  Pigs by Preimmunization  with 
the Carrier Molecule 
B 
C 
D 
E 
F 
Immunization protocol 
Carrier 
preimmunization 
CFA 
B GG-CFA 
(1 ug) 
BGG-CFA 
(5o ug) 
B GG-Salinell 
(500 ug) 
C  FA 
OVA-CFA 
(50 ug) 
Primary~ 
DNPes-BGG 
DNP2s-B GG 
DNP2s-BGG 
DNP2s-BGG 
DNPwOVA 
DNPT-OVA 
Num- 
her 
of 
ani- 
mals 
10 
4 
9 
5 
5 
5 
Anti-DNP 
antibody 
(ug./m  !  )  * 
Day 4  Day 7 
0.10  0.22 
0.13  22.1 
139.8  0.17 
0.10 
0.40 
1.14 
0.22 
0.26 
41.6 
Anti-BGG antibody titers* 
Day 0  I Day 7 
i 
0  0 
362  2048 
3797  56,780 
N.D. ¶  N.D. 
N.D.  N.D. 
N.D.  N.D. 
Boost§ 
0 
1686 
52,983 
* The data are expressed as geometric means. 
:~ 0.2 mg intradermally followed by 0.8 mg intraperitoneally in saline. 
§ Represents the increase in mean antibody levels from day 0 to day 7. 
II Administered intradermally. 
¶  N.D,, not determined. 
and  E).  In  contrast,  guinea  pigs preimmunized  with  BGG  or OVA  in  CFA 
and  then  injected  with  the DNP-homologous  protein conjugate  develop con- 
siderably greater primary anti-DNP responses (Groups B, C, and F). As in the 
preceding experiments, 50/~g rather than  1 #g of BGG in CFA  was  the  most 
effective dose in guinea pigs. A  correlation between  anti-DNP  and anti-BGG 
responses was again noted. No enhancement of the anti-DNP primary response 
was  observed when  guinea pigs were preimmunized intradermally with BGG 
in saline (Group D). 
The rabbit experiments are shown in Table IV. The normal rabbit primary 
anti-DNP  response  to  a  single dose  of DNP28-BGG  in saline is greater  than 
that of guinea pigs (Group A). Preimmunization with 50 #g of native BGG in D.  tI.  KATZ,  W.  E.  PAUL,  E.  A.  GOIDL,  B.  BENACERRA~'  271 
CFA did not enhance significantly the primary anti-DNP response (Group C). 
However, when the optimal dose of the carrier molecule, 1/~g of BGG in CFA, 
was used for preimmunization, the primary anti-DNP response to DNP2s-BGG 
was clearly enhanced (Group B). 
Effect  of  Passively  Transferred Anti-Carrier  Antibody  on  Hapten-Specific 
Primary and Secondary Responses.--As  shown in  the  preceding experiments, 
supplemental  immunization  of  guinea  pigs  and  rabbits  with  BGG  in  CFA 
produced large amounts of circulating anti-BGG antibodies prior to immuni- 
zation with DNP2s-BGG. This raises the question of the role that circulating 
anti-carrier  antibodies  may play in  the  enhanced  anti  hapten  antibody  re- 
sponses. This problem was investigated in the following experiments using the 
same antigen dose and route of administration as in the previous experiments. 
TABLE  IV 
Elicitation of Hapten-Specific Primary Responses in Rabbits 
Immunization protocol  Number  Anti-DNP  antibody (~g/ml)* 
Carrier  of 
Group  preimmunization  Primary:~  animals  Day 4  Day 7 
A  CFA  DNP28-BGG  5  0.16  1.2  (0.59-  2.4) 
B  BGG-CFA  DNP28-BGG  5  0.25  46.8  (29.4-74.4) 
(1 ~g) 
C  BGG-CFA  DNP2s-BGG  5  0.16  4.7  (2.3- 9.6) 
(50 ~g) 
* The data are expressed as geometric means; the range encompassed by 4-1  SE is shown 
within parentheses. 
++ 5 mg intraperitoneally in saline. 
The  experimental  protocols  of  the  guinea  pig  experiments  are  shown  in 
Table V. One group (Group A) was preimmunized with 50/zg of BGG in CFA, 
two groups  (B  and C)  with saline in CFA.  3  wk later,  Group C  guinea pigs 
were injected intravenously with  10 ml  of guinea pig anti-BGG serum (18.2 
mg of antibody) divided in two doses given on 2 successive days. 24 hr after 
the second injection of anti-BGG serum, the standard primary immunization 
with DNP2s-BGG in saline was carried out. Each guinea pig in Groups A and 
B  received 10 ml of normal guinea pig serum prior to primary immunization 
with DNP28-BGG. Guinea pigs in Groups D and E which had been primed with 
DNPT-OVA at  the beginning of the experiment were treated in  an identical 
manner as animals in Groups A and C, respectively. 
As  expected from the  results of the preceding experiments, guinea pigs in 
Groups  A  and  D  manifested  enhanced  primary  and  secondary  anti-DNP 
responses, respectively. Passively transferred anti-BGG serum, however, had 
no enhancing effect upon either a primary (Group C)  or a secondary (Group 272  CARRIER  FUNCTION  IN  ANTI-HAPTEN  RESPONSES 
E)  anti-DNP response in guinea pigs. These data are also presented graphically 
in Fig. 1 and 3. 
The  experimental  protocols for  the  rabbit  experiments are listed in Table 
VI.  1 wk after primary immunization with DNPT-OVA,  one group  (Group A) 
was  preimmunized  with  1  #g  of  BGG  in  CFA,  three  groups  (B,  C,  and  D) 
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Fro. 3.  Enhancement  of hapten-specific primary responses by carrier preimmunization in 
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Animals were preimmunized with either 50 #g of BGG emulsified in CFA or with a saline- 
CFA emulsion. 3 wk later, they received a primary immunization with 1.0 mg of DNP2s-BGG 
in saline. Serum anti-DNP binding activities just prior to primary immunization and on days 
4 and 7 are illustrated. The numbers  in parentheses  refer to the numbers  of animals in the 
given  groups.  The lower panel illustrates the meager  primary anti-DNP response  in non- 
preimmunized  guinea  pigs,  and the failure  of transfused  anti-BGG serum  to augment  this 
response. The upper panel shows the enhanced primary anti-DNP response to DNP-BGG in 
guinea pigs preimmunized with B GG. 
with  saline in  CFA.  4  wk later,  each  rabbit in  Group  C  received  7.5  mg  of 
early rabbit anti-BGG serum,  and  those in  Group D  received 70  mg of late 
anti-BGG serum  intravenously in a  single dose; each rabbit in  Groups A  and 
B  received normal rabbit serum. 24 hr later, standard secondary immunization 
with DNP28-BGG in saline was carried out. Rabbits in Group A  displayed the 
expected enhanced secondary anti-DNP response and those in Group B  showed 
the small secondary response usually seen to DNP-heterologous conjugates. As 
in guinea pigs, passively transferred anti-BGG serum had no enhancing effect D.  H.  KATZ~  W.  E.  PAUL~  E.  A.  GOIDL~  B.  BENACERRAF 
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on the secondary anti-DNP  responses of rabbits  regardless of whether anti- 
serum of presumably low (early) or high (late) avidity was employed (Groups 
C  and D,  respectively). In fact, a  considerable depression of the anti-DNP 
response was observed, particularly with late anti-BGG antiserum. 
Characterization of Anli-DNP Antibodies.-- 
Determinalions  of relalive  amounts  of 3'1  and  3`2  anti-DVP  antibodies:  Two 
types of 7S immunoglobulins, 3'1 and 3`2, have been described in guinea pigs 
(46, 47). Their differences in physical, chemical, and biological properties have 
been  recently reviewed (48).  The relative proportions of 3`1 and 3`2 globulins 
produced by guinea pigs  immunized with hapten-protein  conjugates are  in- 
fluenced by several factors. Antibodies produced following immunization with 
TABLE VI 
Effect of Passive Transfer of Anti-Carrier Antibody on Anti-Hapten  Responses in Rabbits 
Group 
Immunization protocol 
Primary  Supplement  Secondary 
Num-  Anti-DNP antibody  Anti-BGG antibody 
ber of  (/~g/ml)*  P~0  (#g/ml)* 
ani-  Day  Day  Day  Boosts  Day  Day  Boost:~ 
reals  0  4  7  0  7 
A 
B 
C 
D 
DNPT-OVA  1/zg BGG-CFA  DNP~s-BGG  7  4.3  48.0  374.8  370.5  4211  576  534 
Normal Serum§ 
DNPT-OVA  Normal Serum  DNP28-BGG  6  2.4  2.8  27.4  25.0  <25  <25  0 
DNPT-OVA  Early Anti-BGG  DNP2s-BGG  6  4.8  4.0  10.5  5.7  25  <25  --25 
Serum  (7.5 rag) 
DNPT-OVA  Late Anti-BGG  DNP28-BGG  5  4.6  4.1  5.2  0.6  180  50  --130 
Serum  (70 rag) 
* Geometric means. 
~: Represents the increase in mean antibody levels from day 0 to day 7. 
§ Normal serum or anti-BGG serum were injected intravenously 24 hr before DNP2s-BGG challenge. 
[I Amounts of BGG which when added to l ml of antiserum result in 50% precipitation. 
antigens  in  saline  belong  predominantly  to  the  3'i  class,  whereas  antigens 
emulsified in  CFA stimulate  the production of predominantly 3`2  antibodies 
(47).  Since in the present studies primary and secondary immunizations were 
carried  out with soluble antigens in  saline,  and supplemental  immunization 
with BGG in CFA, it was of interest to determine whether the use of adjuvant 
for  the  supplemental  immunization  changed  the  proportions  of  3`1  and  3`2 
anti-DNP  antibodies  produced  following secondary  challenge  with  DNP28- 
BGG. 
Purified 125I-labeled anti-DNP  antibodies  were prepared  from day 7  sera 
of guinea pigs given primary and secondary immunizations with DNPT-OVA 
without supplemental  carrier  preimmunization  (Group A,  Table  I),  and of 
guinea pigs which received DNP28-BGG  for secondary immunization following 
supplemental preimmunization with BGG in CFA (Group D, Table I).  10 #1 
aliquots of '~SI-labeled antibody containing 1, 2, or 5 #g of protein were mixed 
with 25 #1 each of three specific rabbit antisera: (a) anti-3`1 globulin, (b)  anti- D.  H.  KATZ,  W.  E.  PAUL,  E.  A.  GOIDL,  B.  BENACERRAF  275 
3`2-globulin,  and  (c)  anti-F(ab)2q  Control  tubes  contained 25  #l  of  normal 
rabbit  serum.  The  reaction mixtures were  incubated  overnight  at  4°C,  and 
then each whole sample (35 Izl) was counted for total counts per minute (cpm). 
After centrifugation at 2500  rpm for 20 rain,  10 #1  of each supernate was re- 
moved and counted. The percentage of each antibody precipitated by each of 
the specific antisera was calculated in the following way: 
% precipitated =  100 --  cpm of 10 ul supernate (100) 
total cpm/3.5 
The results shown in Table VII demonstrate that both groups produced rela- 
tively larger amounts of  3`1 than  of 3`2 antibodies.  There is  slightly more 3`2 
immunoglobulin  in  the  antibody of  the  group which  received supplemental 
TABLE  VII 
Rdative Proportions of "/1 and "y2 Glob,dins  in Guinea Pig Anti-DNP Antibodies 
Group  Primary  Supplement  Secondary 
Per cent 
Anti-DNP  Per cent  Per cent  precipitated 
antibody  3'1-  3"2-  by Anti- 
(gg/ml)  globulin  globulin  F (ab)~' 
Day 7  serum* 
A  DNPT-OVA  CFA  DNPT-OVA  560  70  33  97 
285  64  33  98 
D  DNP7-OVA  BGG-CFA  DNP28-BGG  650  50  46  95 
(50 ~g)  1020  58  37  98 
* The percentage of antibody precipitated in the control  tubes  containing normal rabbit  serum was less than 2% in 
all  cases. 
BGG immunization, but the small differences observed do not seem significant. 
It  would  appear,  therefore,  that  supplemental  preimmunization  with  free 
BGG in CFA did not affect significantly the proportions of 3`1 and 3'2 anti-DNP 
antibodies produced. Rather, this ratio seems to have been determined by the 
nature of primary immunization. 
Affinity of anti-DNP antibodies for 3It-DNP-L-lysine: The  association con- 
stants  of  anti-DNP  antibodies  obtained  after  the  secondary  anti-DNP  re- 
sponses,  in  both  rabbits  and  guinea  pigs,  were  more  than  107 L/M  (Table 
VIII).  This  was  noted both  in  the  case  of  antibodies  produced by  animals 
which received primary and secondary immunizations with DNP7-OVA  and 
in  those  given  primary immunization  with  DNP7-OVA  and  secondary  im- 
munization with DNP28-BGG after having received a supplemental immuniza- 
tion  with BGG. 
On  the  other hand,  rabbits  and  guinea  pigs  given primary immunization 
with DNP28-BGG, after BGG preimmunization, produced anti-DNP antibodies 
of relatively low affinity (0.14  X  107 or less).  Thus, the affinity of the  anti- 276  CARRIER FUNCTION IN ANTI-HAPTEN RESPONSES 
DNP  antibody was affected by the  time interval  between  the primary DNP- 
protein  immunization  and  the  bleeding,  and  not  by  the  time  between  the 
supplemental  BGG immunization  and  the bleeding. 
TABLE VIII 
A~nity of Primary  and Secondary Response AntI-DNP  Antibodies for  3H-e-DNP-L-Lysine 
Time after primary  Immunization  protocol  immunization 
KF*  Primary  Supplement  Secondary  L/M )< 10' 
Guinea  DNP 7-OVA  CFA  DNP wOVA 
Pigs 
DNPT-OVA  BGG-CFA  DNP2s-BGG 
(50 #g) 
Rabbits 
--  BGG-CFA  DNP2s-BGG 
(50 t~g) 
DNP wOVA  B GG-CFA  DNP 7-OVA 
(50 ~g) 
DNP 7-OVA  B GG-CFA  DNP28-B  GG 
(1 ~g) 
--  BGG-CFA  DNP2s-BGG 
(1 ~g) 
wk 
5  1.8 
2.1 
5  21.7 
17.0 
7.2 
5.8 
3.5 
2.0 
1  0.13 
0.14 
6  25.2 
43.2 
6  13.4 
16.2 
1  0.014 
0.020 
* Average  association  constant  for  3H-DNP-L-Lysine  of  anti-DNP  antibodies  from 
individual animals. 
DISCUSSION 
The  experiments  reported  here  demonstrate  that  secondary  aati-hapten 
antibody  responses  to  hapten-conjugates  of  a  protein  not  used  in  primary 
immunization are markedly enhanced by an interim immunization with the un- 
conjugated protein.  This  observation  confirms the  findings  of Mitchison  (28) 
and  of  Rajewsky,  et  al.  (29).  Furthermore,  preimmunization  with  carrier 
enhances  the  primary  anti-hapten  antibody  response  to  a  hapten-carrier 
complex in both rabbits and guinea pigs. 
Additional  examples  of  augmentation  of  a  response  to  a  given  antigenic 
determinant as a result of a concomitant, or prior, immune response to another 
determinant on the same particle have been described.  Schierman and McBride 
(25) noted enhanced primary antibody responses, in chickens, to weak erythro- 
cyte isoantigens when highly immunogenic isoantigens were also present on the 
same erythrocyte.  Salvin and Smith  (.3, 49)  reported  that  guinea  pigs  immu- 
nized with  protein  antigens  developed  anti-hapten antibodies,  of the ~'1 class, D.  H.  KATZ,  W.  E.  PAUL,  E.  A.  GOIDL,  B.  BENACERRAF  277 
at  an  accelerated  rate  after  immunization  with  hapten  conjugates  of  these 
proteins.  Several  other  investigators have  failed  to  obtain  evidence of  aug- 
mented primary responses to hapten as a consequence of carrier preimmuniza- 
tion (29,50-53). As has been shown in the current paper, however, the conditions 
of immunization are quite crucial  to  the demonstration of this  phenomenon. 
Thus,  carrier preimmunization is most effective when the protein is  adminis- 
tered in complete Freund's adjuvant.  Furthermore, attention to dose is quite 
important.  50 ~g of BGG prepared guinea pigs for significantly greater anti- 
hapten  responses  than  did  1 /~g  of BGG.  In  contrast,  rabbits  manifested  a 
greater anti-hapten  antibody response a  as result of  preimmunization  with  1 
#g of BGG than of 50 #g of BGG. In  addition,  primary immunization with 
hapten-protein conjugates without adjuvant permitted a most effective demon- 
stration of the enhancing effect of carrier preimmunization. 
This enhancing effect, in both primary and secondary anti-hapten responses, 
could not be obtained by the transfer into animals of serum antibody directed 
at c~rrier determinants.  Ant~carrier antibodies obtained both early and late 
in the course of an immune response were ineffective in this regard. However, 
lymphoid  cells  from  syngeneic  animals  immunized  to  carrier  will  transfer 
enhanced  responsiveness  to  animals  which  themselves  have  not  received 
supplemental carrier immunization. This has been demonstrated by the studies 
of Mitchison, with CBA mice (28), and by experiments reported in the second 
paper of this series,  with strain 2 guinea pigs (54). 
This  group  of findings  strongly suggest  that,  in  anti-hapten  antibody re- 
sponses,  an  interaction  of carrier-specific cells with hapten-carrier  conjugate 
is required for maximal stimulation of the precursors of anti-hapten antibody 
producing  cells.  This  cellular  cooperation may well  have  an  analogy in  the 
cooperation  of  antigen  reactive  cells  and  the  precursors  of  plaque  forming 
cells in antibody responses of mice to sheep erythrocytes. In the latter system, 
it has been shown that antigen reactive cells are derived from the thymus and 
do not,  themselves,  secrete antibody (55-58).  Nevertheless,  they are specific 
and they are required for the production of anti- sheep erythrocyte antibody by 
cells derived from the bone marrow.  One may then reasonably ask whether, 
in  the carrier-hapten cooperation, carrier-specific cells are thymus dependent 
antigen reactive cells and hapten-specific cells, bone marrow derived precursors 
of antibody-forming cells.  (It should, of course, be noted that there would also 
be precursors of antibody-producing cells specific for determinants of the car- 
rier  molecules).  Experiments  are  currently in  progress  in  our laboratory  to 
answer these questions. Preliminary results of Mitchison, et al. suggest, indeed, 
that  carrier-specific  cells  in  mice  are  thymus-dependent  lymphocytes  (59). 
The  nature  of  the  interaction  between  carrier-specific  cells  and  hapten- 
specific cells,  in  the development of an anti-hapten  antibody response is not 
clear. Several possible mechanisms may be considered: 
(a) The carrier cell acts as a device to concentrate antigen and to present it 278  CARRIER  FUNCTION  IN  ANTI-HAPTEN  RESPONSES 
to hapten-specific cells,  perhaps  in a  specified  anatomic compartment of the 
lymphoid system. This explanation has been suggested by Mitchison (28,  59). 
(b)  The  stimulation  of  a  hapten-specific  cell  requires  an  interaction  not 
only with antigen but also with the carrier-specific  cell. The latter may provide 
a signal of some sort which is crucial to the differentiation and/or proliferation 
of the hapten-specific cell. 
(c)  The  carrier-specific  cell  secretes  a  special  class  of anti-carrier  antibody 
which must interact with antigen in order  that antigen may then stimulate 
the hapten-specific cell. This antibody appears in the serum in concentrations 
too low for the response to be transferred by serum. 
(d)  The carrier-specific  cell processes the antigen; this processed antigen may 
then specifically stimulate hapten-specific cells. 
A choice among these mechanisms will require detailed information regard- 
ing the  prowrties  of carriers  and  the functions of carrier-specific  cells.  The 
second paper  of this series  describes  some of these  properties  and functions 
(54). 
The  data  presented  in  the  current  study  do  demonstrate  that  both  the 
immunoglobulin class and the affinity of anti hapten antibody are determined 
by the mode and time of primary immunization with hapten-carrier conjugate 
and not by the conditions of the supplemental carrier immunization. Thus, a 
majority of the anti-DNP antibody molecules produced by guinea pigs which 
had been primed with DNPT-OVA  in saline, immunized with BGG in complete 
Freund's adjuvant, and challenged with DNP2s-BGG in saline are  of  the  ~1 
immunoglobulin  class  whereas  ~2  antibodies  predominate  in  the  immune 
response  to  antigens  administered  in  complete  Freund's  adjuvant  (46-48). 
This result is analogous to allotype data of Mitchison et al. in that the class of 
the  anti-hapten  antibody is  determined by  the  primary hapten-carrier  im- 
munization and not by the subsequent carrier immunization (59).  Similarly, 
the affinity of the anti  hapten antibody for ~H-e-DNP-L-lysine  is determined, 
as in conventional immunization, by the length of time after primary immu- 
nization  with the  hapten  conjugate  and  is  not  affected  by  supplemental 
carrier immunization. 
The phenomenon of carrier cell-hapten  cell cooperation may have general 
relevance to immune responses  and is very likely not limited to  the  experi- 
mental models reported here and by others. This is strongly suggested by the 
observation  that  guinea pigs  given primary immunization with DNPT-OVA 
and  secondary  immunization  with  this  same  conjugate  show  considerably 
enhanced anamnestic anti  hapten antibody responses if they have received an 
interim immunization with unconjugated OVA emulsified in complete Freund's 
adjuvant. 
Indeed,  one must  consider whether the stimulation of hapten-specific pre- 
cursors of antibody forming cells always requires the participation of carrier- D.  H.  KATZ,  W.  E.  PAUL,  E.  A.  GOIDL,  B.  BENACERRAF  279 
specific  cells.  According  to  this view,  the  modest hapten-specific  secondary 
responses to DNP2s-BGG in rabbits primed with DNPT-OVA but not receiving 
supplemental BGG immunization  may be ascribed  to  the  few BGG specific 
carrier  cells present  prior  to  BGG  immunization  or  developing early in  the 
course of a primary response. 
SUMMARY 
Preimmunization of either guinea pigs or rabbits to bovine gamma globulin 
(BGG)  prepares  the  animals  for  markedly  enhanced  antibody  responses  to 
2,4-dinitrophenyl-BGG  (DNP-BGG).  This  phenomenon  is  observed  both 
in the primary anti-DNP antibody response to DNP-BGG and in the second- 
ary  anti-DNP  antibody  response  to  DNP-BGG  in  animals  primed  with 
DNP-ovalbumin (DNP-OVA). The BGG preimmunization is most effective if 
the  antigen  is  administered  as  a  complete  Freund's  adjuvant  emulsion;  in 
rabbits, a dose of 1/zg of BGG is more effective than a dose of 50/~g, whereas 
the reverse is true in guinea pigs. Transfusion  of homologous anti-BGG sera 
fails to replace active immunization with BGG in the pr~@aration of animals 
for these  enhanced  anti-DNP  antibody responses.  Both  the  immunoglobulin 
class and the average association constant for e-DNP-z-lysine of the anti-DNP 
antibody  produced  in  these  enhanced  responses  is  determined  by  the  mode 
and  time  of  immunization  with  haptenic  conjugates  and  is  not  appreciably 
influenced by the nature of the carrier preimmunization. 
These studies indicate that the carrier specificity of hapten-specific anamnes- 
tic antibody responses is largely due to the interaction of two independent cell 
associated recognition units,  one specialized for carrier and  the other specific 
for haptenic determinants. 
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